Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(5):547. https://doi.org/10.1007/s00401-007-0278-6.
Article
PubMed Central
Google Scholar
van den Bent MJ, Weller M, Wen PY, Kros JM, Aldape K, Chang S. A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics. Neuro Oncol. 2017;19(5):614–24. https://doi.org/10.1093/neuonc/now277.
Article
CAS
PubMed
PubMed Central
Google Scholar
Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, et al. Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. New Engl J Medicine. 2015;372(26):2499–508. https://doi.org/10.1056/NEJMoa1407279.
Article
CAS
Google Scholar
Zong H, Verhaak RG, Canoll P. The cellular origin for malignant glioma and prospects for clinical advancements. Expert Rev Mol Diagn. 2014;12(4):383–94. https://doi.org/10.1586/erm.12.30.
Article
CAS
Google Scholar
Aldape K, Brindle KM, Chesler L, Chopra R, Gajjar A, Gilbert MR, et al. Challenges to curing primary brain tumours. Nat Rev Clin Oncol. 2019;16(8):509–20. https://doi.org/10.1038/s41571-019-0177-5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Banerjee K, Núñez FJ, Haase S, McClellan BL, Faisal SM, Carney SV, et al. Current approaches for glioma gene therapy and virotherapy. Front Mol Neurosci. 2021;14:621831. https://doi.org/10.3389/fnmol.2021.621831.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu Y, Zhang H, Sun Q, Geng R, Yuan F, Liu B, et al. Immunomodulatory effects of tryptophan metabolism in the glioma tumor microenvironment. Front Immunol. 2021;12:730289. https://doi.org/10.3389/fimmu.2021.730289.
Article
CAS
PubMed
PubMed Central
Google Scholar
Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current perspectives in cancer immunotherapy. Cancers. 2019;11(10):1472. https://doi.org/10.3390/cancers11101472.
Article
CAS
PubMed Central
Google Scholar
Wu F, Wang ZL, Wang KY, Li GZ, Chai RC, Liu YQ, et al. Classification of diffuse lower-grade glioma based on immunological profiling. Mol Oncol. 2020;14(9):2081–95. https://doi.org/10.1002/1878-0261.12707.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tan Y, Zhang S, Xiao Q, Wang J, Zhao K, Liu W, et al. Prognostic significance of ARL9 and its methylation in low-grade glioma. Genomics. 2020;112(6):4808–16. https://doi.org/10.1016/j.ygeno.2020.08.035.
Article
CAS
PubMed
Google Scholar
Jamshidi J, Movafagh A, Emamalizadeh B, Zare Bidoki A, Manafi A, Ghasemi Firouzabadi S, et al. HLA-DRA is associated with Parkinson’s disease in Iranian population. Int J Immunogenet. 2014;41(6):508–11. https://doi.org/10.1111/iji.12151.
Article
CAS
PubMed
Google Scholar
Lee H-S, Yang SK, Hong M, Jung S, Kim BM, Moon JW, et al. An intergenic variant rs9268877 between HLA-DRA and HLA-DRB contributes to the clinical course and long-term outcome of ulcerative colitis. J Crohn’s Colitis. 2018;12(9):1113–21. https://doi.org/10.1093/ecco-jcc/jjy080.
Article
Google Scholar
Chu G, Jiao W, Yang X, Liang Y, Li Z, Niu H. C3, C3AR1, HLA-DRA , and HLA-E as potential prognostic biomarkers for renal clear cell carcinoma. Transl Androl Urology. 2020;9(6):2640656–2656. https://doi.org/10.21037/tau-20-699.
Article
Google Scholar
Wu F, Li GZ, Liu HJ, Zhao Z, Chai RC, Liu YQ, et al. Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma. J Pathology. 2020;251(3):272–83. https://doi.org/10.1002/path.5468.
Article
CAS
Google Scholar
Deng X, Lin D, Zhang X, Shen X, Yang Z, Yang L, et al. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas. J Cell Physiol. 2020;235(10):7321–31. https://doi.org/10.1002/jcp.29633.
Article
CAS
PubMed
Google Scholar
Blum A, Wang P, Zenklusen JC. SnapShot: TCGA-analyzed tumors. Cell. 2018;173(2):530. https://doi.org/10.1016/j.cell.2018.03.059.
Article
CAS
PubMed
Google Scholar
Shi H, Song Y, Song Z, Huang C. CKMT1B is a potential prognostic biomarker and associated with immune infiltration in lower-grade glioma. Plos One. 2021;16(1):e0245524. https://doi.org/10.1371/journal.pone.0245524.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu G, Wang L-G, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J Integr Biology. 2012;16(5):284–7. https://doi.org/10.1089/omi.2011.0118.
Article
CAS
Google Scholar
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(D1):D447–52. https://doi.org/10.1093/nar/gku1003.
Article
CAS
PubMed
Google Scholar
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504. https://doi.org/10.1101/gr.1239303.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thul PJ, Åkesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, et al. A subcellular map of the human proteome. Science. 2017;356(6340). https://doi.org/10.1126/science.aal3321.
Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7. https://doi.org/10.1038/nmeth.3337.
Article
CAS
PubMed
PubMed Central
Google Scholar
Xu S, Li X, Tang L, Liu Z, Yang K, Cheng Q. CD74 correlated with malignancies and immune microenvironment in gliomas. Front Mol Biosci. 2021;8:706949. https://doi.org/10.3389/fmolb.2021.706949.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21(8):938–45. https://doi.org/10.1038/nm.3909.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ali HR, Chlon L, Pharoah PDP, Markowetz F, Caldas C. Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study. Plos Med. 2016;13(12):e1002194. https://doi.org/10.1371/journal.pmed.1002194.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bense RD, et al. Relevance of tumor-infiltrating immune cell composition and functionality for disease outcome in breast cancer. J Natl Cancer I. 2016;109:djw192.
Article
Google Scholar
Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, et al. Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus. 2015;38(1):E6. https://doi.org/10.3171/2014.10.FOCUS12367.
Article
PubMed
PubMed Central
Google Scholar
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, et al. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncol. 2017;18(10):1373–85. https://doi.org/10.1016/S1470-2045(17)30517-X.
Article
CAS
PubMed
Google Scholar
Schalper KA, Rodriguez-Ruiz ME, Diez-Valle R, López-Janeiro A, Porciuncula A, Idoate MA, et al. Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma. Nat Med. 2019;25(3):470–6. https://doi.org/10.1038/s41591-018-0339-5.
Article
CAS
PubMed
Google Scholar
Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, et al. HER2-specific chimeric antigen receptor–modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial. Jama Oncol. 2017;3(8):1094–101. https://doi.org/10.1001/jamaoncol.2017.0184.
Article
PubMed
PubMed Central
Google Scholar
Chai L-P, Wang ZF, Liang WY, Chen L, Chen D, Wang AX, et al. In vitro and in vivo effect of 5-FC combined gene therapy with TNF-α and CD suicide gene on human laryngeal carcinoma cell line Hep-2. Plos One. 2013;8(4):e61136. https://doi.org/10.1371/journal.pone.0061136.
Article
CAS
PubMed
PubMed Central
Google Scholar
Herman JM, Wild AT, Wang H, Tran PT, Chang KJ, Taylor GE, et al. Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results. J Clin Oncol. 2013;31(7):886–94. https://doi.org/10.1200/JCO.2012.44.7516.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lan T, Chen L, Wei X. Inflammatory cytokines in cancer: comprehensive understanding and clinical progress in gene therapy. Cells. 2021;10(1):100. https://doi.org/10.3390/cells10010100.
Article
CAS
PubMed Central
Google Scholar
Yang S, Liu T, Nan H, Wang Y, Chen H, Zhang X, et al. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma. J Cell Physiol. 2020;235(2):1025–35. https://doi.org/10.1002/jcp.29018.
Article
CAS
PubMed
Google Scholar
Jia D, Li S, Li D, Xue H, Yang D, Liu Y. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Aging Albany Ny. 2018;10(4):592–605. https://doi.org/10.18632/aging.101415.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tang J, Pan R, Xu L, Ma Q, Ying X, Zhao J, et al. IL10 hypomethylation is associated with the risk of gastric cancer. Oncol Lett. 2021;21(4):241. https://doi.org/10.3892/ol.2021.12502.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kong X, Xu M, Cui X, Ma L, Cheng H, Hou J, et al. Potential role of macrophage phenotypes and CCL2 in the pathogenesis of Takayasu arteritis. Front Immunol. 2021;12:646516. https://doi.org/10.3389/fimmu.2021.646516.
Article
CAS
PubMed
PubMed Central
Google Scholar
Loreth D, Schuette M, Zinke J, Mohme M, Piffko A, Schneegans S, et al. CD74 and CD44 expression on CTCs in cancer patients with brain metastasis. Int J Mol Sci. 2021;22(13):6993. https://doi.org/10.3390/ijms22136993.
Article
CAS
PubMed
PubMed Central
Google Scholar